Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
bacterial infection
cerebrovascular accident
cerebrovascular accident, mimics
chlorpropamide
coma
diabetes mellitus
drug induced neurologic disorders
genetic neurologic disorders
hemiparesis
hypoglycemia
hypoglycemic agent, oral
hypoglycemic coma
iatrogenic neurologic disorders
insulin
level of consciousness, decreased
mimics
mortality
old age, neurology of
optic neuropathy
optic neuropathy, toxic
seizure
tolazamide
transketolase
visual loss
Wernicke's encephalopathy
Showing articles 650 to 700 of 4499 << Previous Next >>

Embolic Stroke, Atrial Fibrillation, and Microbleeds
Stroke 47:904-907, Diener, H-C.,et al, 2016

Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia
Stroke 47:1825-1830, Myslimi, F.,et al, 2016

Should Atrial Fibrillation Patients with only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
Stroke 47:1831-1836, Fauchier, L.,et al, 2016

Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage
Stroke 47:1837-1843, Ottosen, T.P.,et al, 2016

Postmenopausal Hormone Therapy and Risk of Stroke
Stroke 47:1734-1741, Canonico, M.,et al, 2016

Safety and Diagnostic Value of Brain Biopsy in HIV patients: a Case Series and Meta-Analysis of 1209 Patients
JNNP 87:722-733, Lee, A.M.,et al, 2016

Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016

Ticagrelor Versus Aspirin in Acute Stroke or Transient Ischemic Attack
NEJM 375:35-43, Johnston, S.C.,et al, 2016

Platelet Transfusion versus Standard Care after Acute Stroke Due to Spontaneous Cerebral Haemorrhage Associated with Antiplatelet Therapy (PATCH): A Randomised, Open-Label, Phase 3 Trial
Lancet 387:2605-2613, Baharoglu, M.,et al, 2016

And Why Not Thrombolysis in the Ambulance (At Least for Some)?
Neurol 87:214-219, Rosenberg, G. & Steiner, I., 2016

Rebound Syndrome in Patients with Multiple Sclerosis after Cessation of Fingolimod Treatment
JAMA Neurol 73:790-794, Hatcher, S.E.,et al, 2016

Effects of Aspiring on Risk and Severity of Early Recurrent Stroke After Transient Ischaemic Attack and Ischaemic Stroke: Time-Course Analysis of Randomised Trials
Lancet: 388:365-375, 312, Rothwell, P.M.,et al, 2016

International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016

Outcomes with Edoxaban Versus Warfarin in Patients with Previous Cerebrovascular Events
Stroke 47:2075-2082, Rost, N.S.,et al, 2016

Repeated Intravenous Thrombolysis for Early Recurrent Stroke
Stroke 47:2133-2135, Kahles, T.,et al, 2016

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic STroke
Stroke 47:581-641, Demaerschalk, B.M.,et al, 2016

Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke
Stroke 47:450-456, Gensicke, H.,et al, 2016

Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016

Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
JAMA Neurol 73:169-177,155, Purrucker, J.C.,et al, 2016

Telemedicine in Prehospital Stroke Evaluation and Thrombolysis
JAMA Neurol 73:162-168, Itrat, A.,et al, 2016

Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation
JAMA Neurol 73:197-202, Auriel, E.,et al, 2016

Rapid Multifocal Neurologic Decline in an Immunocompromised Patient
JAMA Neurol 73:226-231, Kromm, J.A.,et al, 2016

Carotid Near-Occlusion: A Comprehensive Review, Part 2- Prognosis and Treatment, Pathophysiology, Confusions, and Areas for Improvement
AJNR 37:200-204, Johansson, E. & Fox, A.J., 2016

Statin-Associated Autoimmune Myopathy
NEJM 374:664-669, Mammen, A.L., 2016

Clinicopathologic Conference, Cerebral Mucormycosis
NEJM 374:671-680, Case 5-2016, 2016

Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016

Community-Acquired Bacterial Meningitis in Adults with Cancer or a History of Cancer
Neurol 86:860-866, Costerus, J.M.,et al, 2016

Antibiotic-Associated Encephalopathy
Neurol 86:963-971, Bhattacharyya, S.,et al, 2016

Clinical Manifestations and Evaluation of Adults with Suspected Native Valve Endocarditis
UpToDate Feb, Sexton, D.J. & Fowler,Jr., V.G., 2016

Cost-Effectiveness of Endovascular Thrombectomy in Patients with Acute Ischemic Stroke
Neurol 86:1053-1059, Aronsson, M.,et al, 2016

Streamlined Hyeracute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression is Stroke Mimic
Stroke 47:1012-1017, Goyal, M.S.,et al, 2016

Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 47:1127-1130, Purrucker, J.C.,et al, 2016

Clinicopathologic Conference, Cerebral Infarction from Internal Carotid Occlusion Related to Sickle Cell Arteriopathy
NEJM 374:1265-1275, Case 10-2016, 2016

Metronidazole-Associated Encephalopathy
NEJM 374:1465, Baden, L.R., 2016

A 76-Year-Old Man with Acute-Onset Left-Sided Weakness and Numbness
Neurol 86:e156-e160, Renthal, W.,et al, 2016

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
NEJM 374:1533-1542,1577, Amarenco, P.,et al, 2016

Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome
Ann Neurol 79:560-568, Park, J.M.,et al, 2016

Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort
Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016

Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 387:1921-1927,1882, Villiger, P.M.,et al, 2016

Three Territory DWI Acute Infarcts: Diagnostic Value in Cancer-Associated Hypercoagulation Stroke (Trousseau Syndrome)
AJNR 37: Nov, Finelli, P.F. & Nouh, A., 2016

Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016

Risk of Cerebral Venous Thrombosis in Obese Women
JAMA Neurol 73:579-584, Zuurbier, S.M.,et al, 2016

Which Oral Anticoagulation for Atrial Fibrillation?
JAMA 315:2117-2118, The Medical Letter, 2016

Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients
Stroke 47:1555-1561, Shah, A.,et al, 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Risk of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and High Cerebral Microbleed Burden
JAMA Neurol 73:675-683,632, Tsivgoulis, G.,et al, 2016

Human Neurexin-3a Antibodies Associate with Encephalitis and Alter Synapse Development
Neurol 86:2235-2242,2222, Gresa-Arribas, N.,et al, 2016

Imaging, Intervention, and Workflow in Acute Ischemic Stroke: The Calgary Approach
AJNR 37:978-984, Zerna, C.,et al, 2016

Principles and Clinical Application of Dual-Energy Computed Tomography in the Evaluation of Cerebrovascular Disease
J Clin Imaging Sci 6:1-9, Hsu, C.C.T.,et al, 2016

Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Eur J Cancer 54:139-148, Michot, JM,.,et al, 2016



Showing articles 650 to 700 of 4499 << Previous Next >>